ctrl K

Watchlist Price Alert

Estrella Immunopharma Inc... (ESLA)

NASDAQ: ESLA · Real-Time Price · USD

0.94

0.11 (12.68%)

At close: Jun 04, 2025, 3:59 PM

0.95

0.27%

After-hours: Jun 04, 2025, 05:37 PM EDT

Estrella Immunopharma Income Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021
Revenue	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a
Operating Income	-7.31M	-1.57M	-1.69M	-733.69K
Interest Income	n/a	654.07K	1.43K	n/a
Pretax Income	-7.31M	-915.46K	-1.69M	-733.69K
Net Income	-7.31M	-996.1K	-1.69M	-733.69K
Selling & General & Admin	3.2M	1.37M	296.25K	276.46K
Research & Development	4.11M	n/a	1.39M	457.23K
Other Expenses	n/a	-201.31K	-70.15K	n/a
Operating Expenses	7.31M	1.57M	1.69M	733.69K
Interest Expense	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	7.31M	1.57M	1.69M	733.69K
Income Tax Expense	1.63K	80.65K	-235.14K	-206.3K
Shares Outstanding (Basic)	35.2M	5.76M	5.85M	35.2M
Shares Outstanding (Diluted)	35.2M	5.76M	5.85M	35.2M
EPS (Basic)	-0.21	-0.17	-0.29	-0.02
EPS (Diluted)	-0.21	-0.17	-0.29	-0.02
EBITDA	-7.31M	-915.46K	-247.72K	-733.69K
EBIT	-7.31M	-915.46K	-247.72K	n/a
Depreciation & Amortization	n/a	228.49K	236.56K	206.3K